Ensuring Patient Safety With Anti-Counterfeiting and Regulation Reporting

SymbolPriceChangeAXW.PA14.80-0.12{“s” : “axw.pa”,”k” : “a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00″,”o” : “”,”j” : “”}

PHOENIX–(BUSINESS WIRE)–
Axway (Paris:AXW.pa – News), a Business Interaction Networks company, announced
currently that it will be vocalization during a 2^nd annual
Pharmaceutical Serialization Traceability Summit in Geneva,
Switzerland on

Nov 2-4, 2011. Axway is during a forefront of technological
innovations around track
and snippet technology and will plead how a record can be
leveraged globally to strengthen companies and approve with a new coming
regulations.

The session, patrician “Drug anti-counterfeiting and regulation
reporting: how to strike dual birds with one mill and advantage patient
safety!” will concentration on end-to-end prominence of a supply sequence and
give unsentimental superintendence on how manufacturers can cope with complex
cross-border regulatory environments. With a World Health Organization
estimating that adult to one percent of medicines accessible in the
grown universe are expected counterfeit, rising to 10 percent globally,
there is a transparent need for a attention to work together to residence the
outrageous risks acted by counterfeit
drugs.

“As an active actor in general standards and regulation
for healthcare, Axway is unapproachable of a pioneering work with leading
organizations and curative companies,” pronounced Bruno Cambounet, vice
boss sales and operations, Healthcare EMEA, Axway. “Modern supply
bondage can be impossibly formidable and organisations need complete
clarity so that patients aren’t put during risk. Axway’s
Track Trace solution enables organizations to accommodate regulatory
standards – but, during a aloft level, we are also committed to helping
guarantee supply bondage by loyal prominence that in spin protects
a gratification of patients.”

WHAT:

WHO:

Bruno Cambounet, Vice President Sales Operations, Healthcare EMEA,
Axway

WHEN:

The Pharmaceutical Serialization Traceability Summit is being hold on
Nov 2-4, 2011 during Crowne Plaza, Geneva, Switzerland. The conference
is an event to plead a latest developments and regulations in
curative serialization during an general spin with leading
experts from around a world.

For some-more information on a Pharmaceutical Serialization Traceability
conference: http://www.pharmaserialisation.com/Event.aspx?id=558904

To report a assembly with Axway during a event: http://www.axway.com/events/event/join-axway-pharmaceutical-serialisation-and-traceability-summit-2011

To learn some-more about Axway’s Track Trace solutions: http://www.axway.com/products-solutions/integration/track-trace

Read a associated box study: AstraZeneca
Combats Counterfeit Drugs, Enhances Patient Safety and Protects Brand
Integrity with Axway Track Trace and GS1 EPCIS

Follow Axway on Twitter: http://twitter.com/Axway

About Axway

Axway (NYSE Euronext: AXW), a Business Interaction Networks company,
is a program and services association purebred in France with
domicile in Phoenix, Arizona. Established in 2001, Axway serves more
than 11,000 organizations in 100 countries, with offices around the
globe. Our award-winning products, solutions and services capacitate the
business-critical exchange compulsory to accelerate opening within
and among enterprises – while providing management, confidence and
governance on interactions via business networks. Axway’s
industry-leading offerings include: business-to-business integration,
managed record transfer, secure email, business operations monitoring,
routine government and temperament validation solutions, as good as
veteran and managed services, cloud solutions, and
Software-as-a-Service. More information is accessible during www.axway.com.